(Q36816153)

16 August 2017

1 reference

title

Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management (English)

1 reference

16 August 2017

1 reference

1 reference

Man-Fung Yuen

1

1 reference

16 August 2017

publication date

19 April 2007

1 reference

Journal of Gastroenterology and Hepatology

16 August 2017

published in

1 reference

16 August 2017

volume

22

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

973-976

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

16 August 2017

1 reference

Natural history of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Infection of peripheral mononuclear blood cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Prognostic factors in severe exacerbation of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Chronic type B hepatitis and the "healthy" HBsAg carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04938.X

10.1111/J.1440-1746.2007.04938.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference